Syncona Shs GBP (GB:SYNC) has released an update.
Syncona Limited, a life sciences investment company, reports a total of 629,973,994 voting rights as of November 2024, following adjustments for treasury shares. The company continues to focus on creating transformational healthcare solutions through its diverse portfolio, aiming to deliver substantial returns while addressing high unmet medical needs.
For further insights into GB:SYNC stock, check out TipRanks’ Stock Analysis page.